The WHO has recommended two new vaccine candidates developed by Oxford University and Moderna for an ongoing clinical trial in the Democratic Republic of
Nigeria has heightened Ebola surveillance and preparedness after Kenya confirmed an imported Bundibugyo virus case linked to the outbreak in the Democratic Republic of